Development and characterization of nanocarriers for topical treatment of psoriasis by using combination therapy
Source abstract
Abstract
Psoriasis is an autoimmune, chronic, inflammatory skin disease characterized by epidermal hyperplasia, proliferation of blood vessels, and infiltration of leukocytes in dermis and epidermis. Several immunosuppressants such as methotrexate (MXT) and cyclosporine are used but they are associated with adverse effects due to down regulation of immune system. Numerous approaches have been explored to overcome the problems of conventional topical system such as high frequency of application, impermeability to skin barrier, and limited efficacy. Photodynamic therapy is another non-invasive technique currently used for skin diseases. The combination of two drugs is also commonly observed to achieve more effective therapy. In the present study, antipsoriatic activity of niosomal formulations for the treatment of psoriasis in combination with narrow and broad band UV radiation had been explored in experimental animal model.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Psoriasis: Treatment and Pathogenesis · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (18)
Show source-provided references
1. Ali MF · Med Sci Monit · 2008 · 14 · 66
2. Almutawa F · Am J Clin Dermatol · 2013 · 14 · 8710.1007/s40257-013-0015-y ↗
3. 10.1080/0363904080244864610.1080/03639040802448646 ↗
4. Brady SP · J Am Acad Dermatol · 2004 · 50 · 7710.1016/S0190-9622(03)02801-9 ↗
5. Dayal S · Indian J Dermatol Venereol Leprol · 2010 · 76 · 53310.4103/0378-6323.69081 ↗
6. 10.1111/j.1365-2230.2012.04440.x10.1111/j.1365-2230.2012.04440.x ↗
7. Dubey V · J Control Release · 2007 · 123 · 14810.1016/j.jconrel.2007.08.005 ↗
8. Garg T · Crit Rev Ther Drug Carrier Syst · 2012 · 29 · 110.1615/CritRevTherDrugCarrierSyst.v29.i1.10 ↗
9. Hashizume H · J Dermatol · 2007 · 34 · 43010.1111/j.1346-8138.2007.00305.x ↗
10. Ko YT · AAPS PharmSciTech · 2012 · 13 · 37310.1208/s12249-012-9757-8 ↗
11. Kocak AY · Cutan Ocul Toxicol · 2013 · 32 · 33310.3109/15569527.2013.779278 ↗
12. Lunter D · Skin Pharmacol Physiol · 2013 · 26 · 13910.1159/000348464 ↗
13. Mason AR · Cochrane Database Syst Rev · 2013 · 3
14. Nagle A · J Liposome Res · 2011 · 21 · 13410.3109/08982104.2010.492476 ↗
15. 10.1159/00002993510.1159/000029935 ↗
16. 10.4103/2230-973X.10700210.4103/2230-973X.107002 ↗
17. Silva FS · Mutat Res · 2013 · 753 · 4210.1016/j.mrgentox.2012.12.017 ↗
18. Ruchusatsawat K · Hum Pathol · 2011 · 42 · 187810.1016/j.humpath.2011.02.005 ↗